Key facts
- This page summarizes CR Group L.P.'s Form 4 filing for T2 Biosystems, Inc. (TTOO).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 13 May 2024, 18:19.
CR Group L.P. - 09 May 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- TTOO
- Reported as of
- 09 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 May 2024, 18:19:50 UTC
- Prior SEC filing
- 07 May 2024
- Source filing
- View source filing
- Reporting owner signature
-
/s/ Nathan D. Hukill, authorized signatory for CR Group LP, CRG Partners III LP, CRG Partners III - Parallel Fund (A) LP, CRG Partners III (Cayman) Unlev AIV I LP, CRG Partners III (Cayman) Lev AIV I LP, and CRG...
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
CR Group L.P. filed Form 4 for T2 Biosystems, Inc. (TTOO) on 13 May 2024.
Change
- Previous filing in this sequence was filed on 07 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TTOO
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,716,048
- Change %
- +60%
- Price
- Shares after
- 4,595,977
- Date
- 09 May 2024
- Ownership
- By CRG Partners III - Parallel Fund B (Cayman) L.P.
- Footnotes
- F1, F2
TTOO
transaction
Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +108,752
- Change %
- +2.4%
- Price
- Shares after
- 4,704,729
- Date
- 09 May 2024
- Ownership
- By CRG Partners III - Parallel Fund B (Cayman) L.P.
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TTOO
transaction
Derivative
Series A Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -17,160
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 09 May 2024
- Ownership
- By CRG Partners III - Parallel Fund B (Cayman) L.P.
- Underlying class
- Common Stock
- Underlying amount
- 1,716,048
- Exercise price
- Footnotes
- F1, F2
TTOO
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- $0
- Shares
- -10,875
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 09 May 2024
- Ownership
- By CRG Partners III - Parallel Fund B (Cayman) L.P.
- Underlying class
- Common Stock
- Underlying amount
- 108,752
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each share of Series A Preferred Stock converted into 100 shares of Common Stock for no additional consideration and has no expiration date.
Footnote F2
CR Group L.P. may be deemed to beneficially own these shares by virtue of its position as the investment manager for the CRG Entities.
Footnote F3
Each share of Series B Preferred Stock converted into 10 shares of Common Stock for no additional consideration and has no expiration date.